Citi is maintaining its Buy rating on shares of Allscripts Healthcare Solutions, Inc. MDRX.
“Allscripts filed an 8-K after market close in which it made three announcements: 1) A new credit arrangement reduces interest margin for borrowings under the senior credit facilities by 75 bps,” Citi writes.
“2) MDRX entered into an agreement with Affiliated Computer Services (ACS) where ACS will provide remote hosting services for the company's Sunrise acute care clients; and 3) MDRX' Chief Technology Officer, John Gomez, is resigning to pursue other interests.
“Despite the savings from the credit agreement and outsourcing, we are disappointed to see Gomez go and have some concerns with hosting strategy. The change to the interest rates could be worth $0.01- $0.02 in 2011. We see the news as a modest incremental negative for the company.”
Allscripts Healthcare closed Wednesday at $22.49.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst RatingsAllscripts HealthcareCitiData Processing & Outsourced ServicesHealth CareHealth Care TechnologyInformation TechnologyJohn Gomez
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in